Cargando…

Differential expression of G(s) in a murine model of homocysteinemic heart failure

High plasma homocysteine levels are a known risk factor in heart failure and sudden cardiac death. The G proteins, G(s) (stimulatory) and G(i) (inhibitory), are involved in calcium regulation; overexpression has pathological consequences. The aims of this study were to examine the differential expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacek, Thomas P, Sen, Utpal, Tyagi, Neetu, Vacek, Jonathan C, Kumar, Munish, Hughes, William M, Passmore, John C, Tyagi, Suresh C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672463/
https://www.ncbi.nlm.nih.gov/pubmed/19436674
_version_ 1782166542389084160
author Vacek, Thomas P
Sen, Utpal
Tyagi, Neetu
Vacek, Jonathan C
Kumar, Munish
Hughes, William M
Passmore, John C
Tyagi, Suresh C
author_facet Vacek, Thomas P
Sen, Utpal
Tyagi, Neetu
Vacek, Jonathan C
Kumar, Munish
Hughes, William M
Passmore, John C
Tyagi, Suresh C
author_sort Vacek, Thomas P
collection PubMed
description High plasma homocysteine levels are a known risk factor in heart failure and sudden cardiac death. The G proteins, G(s) (stimulatory) and G(i) (inhibitory), are involved in calcium regulation; overexpression has pathological consequences. The aims of this study were to examine the differential expression of G(s) G protein and G(i) in the hearts of hyperhomocysteinemic (Hhcy) mice, and to determine if homocysteine (Hcy) acts as an agonist in cell culture to mediate the change in G protein isoforms. To create Hhcy, heterozygous cystathionine-β-synthase (CBS) knockout (KO) mice were used. Mice were sacrificed, hearts were excised, cardiac tissue homogenates were prepared, and Western blots were performed. The results suggested that G(s) G protein was downregulated in cardiac tissue of heterozygous CBS KO mice to 46% that of control hearts. However, the intracellular G(i) G protein content remained the same in heterozygous CBS KO mice. Transformed cardiomyocyte HL-1 cells were treated with varying concentrations of homocysteine. The results suggested no detectable differential G(s) and G(i) expression. This suggested that Hcy did not act as an agonist in vitro to alter G protein content, but that Hcy produced some other in vivo effects to incur these results.
format Text
id pubmed-2672463
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26724632009-08-08 Differential expression of G(s) in a murine model of homocysteinemic heart failure Vacek, Thomas P Sen, Utpal Tyagi, Neetu Vacek, Jonathan C Kumar, Munish Hughes, William M Passmore, John C Tyagi, Suresh C Vasc Health Risk Manag Original Research High plasma homocysteine levels are a known risk factor in heart failure and sudden cardiac death. The G proteins, G(s) (stimulatory) and G(i) (inhibitory), are involved in calcium regulation; overexpression has pathological consequences. The aims of this study were to examine the differential expression of G(s) G protein and G(i) in the hearts of hyperhomocysteinemic (Hhcy) mice, and to determine if homocysteine (Hcy) acts as an agonist in cell culture to mediate the change in G protein isoforms. To create Hhcy, heterozygous cystathionine-β-synthase (CBS) knockout (KO) mice were used. Mice were sacrificed, hearts were excised, cardiac tissue homogenates were prepared, and Western blots were performed. The results suggested that G(s) G protein was downregulated in cardiac tissue of heterozygous CBS KO mice to 46% that of control hearts. However, the intracellular G(i) G protein content remained the same in heterozygous CBS KO mice. Transformed cardiomyocyte HL-1 cells were treated with varying concentrations of homocysteine. The results suggested no detectable differential G(s) and G(i) expression. This suggested that Hcy did not act as an agonist in vitro to alter G protein content, but that Hcy produced some other in vivo effects to incur these results. Dove Medical Press 2009 2009-04-08 /pmc/articles/PMC2672463/ /pubmed/19436674 Text en © 2009 Dove Medical Press Limited. All rights reserved
spellingShingle Original Research
Vacek, Thomas P
Sen, Utpal
Tyagi, Neetu
Vacek, Jonathan C
Kumar, Munish
Hughes, William M
Passmore, John C
Tyagi, Suresh C
Differential expression of G(s) in a murine model of homocysteinemic heart failure
title Differential expression of G(s) in a murine model of homocysteinemic heart failure
title_full Differential expression of G(s) in a murine model of homocysteinemic heart failure
title_fullStr Differential expression of G(s) in a murine model of homocysteinemic heart failure
title_full_unstemmed Differential expression of G(s) in a murine model of homocysteinemic heart failure
title_short Differential expression of G(s) in a murine model of homocysteinemic heart failure
title_sort differential expression of g(s) in a murine model of homocysteinemic heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672463/
https://www.ncbi.nlm.nih.gov/pubmed/19436674
work_keys_str_mv AT vacekthomasp differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT senutpal differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT tyagineetu differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT vacekjonathanc differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT kumarmunish differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT hugheswilliamm differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT passmorejohnc differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure
AT tyagisureshc differentialexpressionofgsinamurinemodelofhomocysteinemicheartfailure